1. (Curcumin+sildenafil) enhances the efficacy of 5FU and anti‐PD1 therapies in vivo. Issue 10 (27th January 2020) Authors: Dent, Paul; Booth, Laurence; Roberts, Jane L.; Poklepovic, Andrew; Hancock, John F. Journal: Journal of cellular physiology Issue: Volume 235:Issue 10(2020:Oct.) Page Start: 6862 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells. Issue 9 (2nd September 2017) Authors: Booth, Laurence; Roberts, Jane L.; Poklepovic, Andrew; Dent, Paul Journal: Cancer biology & therapy Issue: Volume 18:Issue 9(2017) Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Automated determination of metastases in unstructured radiology reports for eligibility screening in oncology clinical trials. (December 2013) Authors: Petkov, Valentina I; Penberthy, Lynne T; Dahman, Bassam A; Poklepovic, Andrew; Gillam, Chris W; McDermott, James H Journal: Experimental biology and medicine Issue: Volume 238:Number 12(2013) Page Start: 1370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours. Issue 5 (30th May 2022) Authors: Kasi, Pashtoon Murtaza; Chakrabarti, Sakti; Sawyer, Sarah; Krainock, Michael; Poklepovic, Andrew; Ansstas, George; Maninder, Minu; Malhotra, Meenakshi; Ensor, Joe; Gao, Ling; Eroglu, Zeynep; Ellers, Sascha; Billings, Paul; Rodriguez, Angel; Aleshin, Alexey Journal: BMJ open Issue: Volume 12:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibition. Issue 5 (4th May 2019) Authors: Booth, Laurence; Roberts, Jane L.; Spiegel, Sarah; Poklepovic, Andrew; Dent, Paul Journal: Cancer biology & therapy Issue: Volume 20:Issue 5(2019) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immunotherapy for Metastatic Melanoma with Right Atrial Involvement in a Patient with Rheumatoid Arthritis. (28th December 2017) Authors: Benson, Zachary; Gordon, Sarah; Nicolato, Patricia; Poklepovic, Andrew Other Names: Jamil Kaiser Academic Editor. Journal: Case reports in oncological medicine Issue: Volume 2017(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells. Issue 5 (4th May 2019) Authors: Booth, Laurence; Roberts, Jane L.; Sander, Cindy; Lalani, Alshad S.; Kirkwood, John M.; Hancock, John F.; Poklepovic, Andrew; Dent, Paul Journal: Cancer biology & therapy Issue: Volume 20:Issue 5(2019) Page Start: 700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Neratinib augments the lethality of [regorafenib + sildenafil]. Issue 4 (10th September 2018) Authors: Booth, Laurence; Roberts, Jane L.; Rais, Rumeesa; Cutler, Richard E.; Diala, Irmina; Lalani, Alshad S.; Hancock, John F.; Poklepovic, Andrew; Dent, Paul Journal: Journal of cellular physiology Issue: Volume 234:Issue 4(2019:Apr.) Page Start: 4874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1/2, and YAP/TAZ signaling. Issue 11 (8th January 2020) Authors: Dent, Paul; Booth, Laurence; Poklepovic, Andrew; Martinez, Jennifer; Hoff, Daniel Von; Hancock, John F. Journal: Journal of cellular physiology Issue: Volume 235:Issue 11(2020:Nov.) Page Start: 7889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Neratinib kills B‐RAF V600E melanoma via ROS‐dependent autophagosome formation and death receptor signaling. (4th September 2021) Authors: Dent, Paul; Booth, Laurence; Poklepovic, Andrew; Kirkwood, John M. Journal: Pigment cell & melanoma research Issue: Volume 35:Number 1(2022) Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗